yingweiwo

CGRP Receptor

CGRP Receptor

Calcitonin-receptor-like receptor (CRLR), a type II (family B) G-protein-coupled receptor, and receptor-activity-modifying protein 1 (RAMP1), a single-membrane-pass protein, combine to form the CGRP receptor. Both CGRP binding and CLR cell-surface expression require RAMP1. A GPCR from family B is the CLR.

The trigeminal system produces large amounts of the neuropeptide CGRP, which is also widely expressed in the peripheral and central nervous systems. Vasodilation, the perception of painful stimuli, and inflammation are just a few of the roles that CGRP plays. Through interactions with its receptors, CGRP brings about biological effects. The CGRP-A and CGRP-B subtypes of CGRP receptors exist.

CGRP Receptor related products

Structure Cat No. Product Name CAS No. Product Description
Adrenomedullin (1-50), rat V77286 Adrenomedullin (1-50), rat Adrenomedullin (1-50), rat is a 50-amino-acid polypeptide that induces arterial vasodilation by activating the CGRP1 receptor.
Adrenomedullin (16-31), human TFA V77824 Adrenomedullin (16-31), human TFA Adrenomedullin (16-31), human TFA is the 16-31 amino acid (AA) fragment of human adrenomedullin (hADM).
Adrenotensin (human) (Pro-ADM-153-185 (human)) V71610 Adrenotensin (human) (Pro-ADM-153-185 (human)) 166546-72-1 Adrenotensin (human) (Pro-ADM-153-185 (human)) is the 153-185 fragment of the adrenotensin (Adrenotensin) precursor peptide.
Adrenotensin (human) TFA V114582 Adrenotensin (human) TFA Human adrenaline (Pro-ADM-153-185 (human)) TFA is the 153-185 fragment of the adrenaline precursor peptide.
BMS-846372 V116154 BMS-846372 1190363-03-1 BMS-846372 (compound 5) is an orally effective CGRP antagonist (Ki = 0.07 nM).
Cagrilintide acetate V77174 Cagrilintide acetate Cagrilintide acetate is a non-selective AMYR/CTR agonist and long-acting acylating amylase analog.
Calcitonin (salmon) (acetate) V86578 Calcitonin (salmon) (acetate) 158000-61-4 Calcitonin (salmon) (acetate) is the acetate form of calcitonin salmon.
Calcitonin Gene Related Peptide (CGRP) II, rat TFA V77172 Calcitonin Gene Related Peptide (CGRP) II, rat TFA Calcitonin Gene Related Peptide (CGRP) II, rat TFA, an activator of CGRP receptors, is a potent and long-lasting vasodilator.
Calcitonin-13C6,15N4 (salmon) TFA V106116 Calcitonin-13C6,15N4 (salmon) TFA Calcitonin-13C6,15N4 (Salmon) (Salmon Calcitonin-13C6,15N4) TFA is 13C and 15N labeled calcitonin (Salmon).
CGRP antagonist 6 V96718 CGRP antagonist 6 CGRP antagonist 6 (Compound 23) is a CGRP receptor antagonist (Ki: 0.84 nM).
Chrysin 6-C-glucoside 8-C-arabinoside V51239 Chrysin 6-C-glucoside 8-C-arabinoside 185145-34-0 Chrysin 6-C-glucoside 8-C-arabinoside inhibits the release of CGRP and the activation of TRPV1 channels.
CRSP-1 V102473 CRSP-1 697327-12-1 CRSP-1 is calcitonin receptor stimulating peptide-1.
CTR/AMYR modulator-1 V114445 CTR/AMYR modulator-1 3097482-67-9 CTR/AMYR modulator-1 (compound 103) is a calcitonin/amyrin receptor modulator.
Desfluoro-BMS-694153 V109058 Desfluoro-BMS-694153 773886-89-8 Desfluoro-BMS-694153 (compound 3) is a calcitonin gene-related peptide receptor (CGRP) antagonist with a Ki value of 0.01 nM.
GRA Ex-25 V3059 GRA Ex-25 307983-31-9 GRA Ex-25 is a novel and potent inhibitor of glucagon receptor with IC50 of 56 and 55 nM for rat and human glucagon receptors, respectively.
HTL22562 V71608 HTL22562 2097085-63-5 HTL22562 is a calcitonin gene-related peptide (CGRP) receptor blocker (antagonist) indicated for acute investigation in migraine.
MK-3207 V4317 MK-3207 957118-49-9 MK-3207 is a novel, potent and orally bioactive CGRP (Calcitonin gene related peptide) receptor antagonist with IC50 and Ki of 0.12 nM and 0.022 nM, it is highly selective versus human AM1, AM2, CTR, and AMY3.
MK-3207 HCl V1495 MK-3207 HCl 957116-20-0 MK-3207 HCl (MK-3207; MK3207), the hydrochloride salt of MK3207, is a novel, potent and orally bioactive CGRP (Calcitonin gene related peptide) receptor antagonist with important biological activity.
PCC0105005 V111240 PCC0105005 2921670-99-5 PCC0105005 is a dual-target CGRP receptor antagonist (IC50 = 1.01 nM) and a 5-HT1F receptor partial agonist (EC50 = 77.91 nM).
Rimegepant (BMS927711) V4067 Rimegepant (BMS927711) 1289023-67-1 Rimegepant (formerly known as BMS-927711; Nurtec ODT) is a highly potent, selective, orally bioavailable, cometitive calcitonin gene-related peptide (CGRP) receptor antagonist with aKivalue of 0.027 nM.
Contact Us